Pancreatic Cancer Research

ResearcherUniversität UlmActive in the last 2 years

André L. Mihaljević

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1902-657X; OpenAlex author ID A5074952419. Sources: OpenAlex.

Their work

Papers
15 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
61
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 3 papers · 2020: 3 papers · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers

Papers 15

  1. ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. Co-author DOI 10.1038/s41388-025-03530-w↗
  2. Pancreatic cancer patient-derived organoids capture therapy response and tumor evolution Co-author DOI 10.1101/2025.04.24.650216↗
  3. Long-term recurrence-free survival following pancreatic surgery with HIPEC treatment for locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1136/bcr-2023-258626↗
  4. Induction Chemotherapy with FOLFIRINOX for Locally Advanced Pancreatic Cancer: A Simple Scoring System to Predict Effect and Prognosis. Co-author DOI 10.1245/s10434-022-12569-y↗
  5. Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve. Co-author DOI 10.1097/sla.0000000000004054↗
  6. Periarterial divestment in pancreatic cancer surgery. First author DOI 10.1016/j.surg.2020.08.030↗
  7. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53. Co-author DOI 10.1053/j.gastro.2021.07.030↗
  8. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003270↗
  9. Cavernous transformation of the portal vein in pancreatic cancer surgery-venous bypass graft first. Co-author DOI 10.1007/s00423-020-01974-0↗
  10. Top ten research priorities for pancreatic cancer therapy. Last author DOI 10.1016/s1470-2045(20)30179-0↗
  11. Fifty Years of Surgery for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001634↗
  12. Meta-analysis of recurrence pattern after resection for pancreatic cancer. First author DOI 10.1002/bjs.11295↗
  13. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX. Co-author DOI 10.1016/j.ejso.2019.03.039↗
  14. Radical pancreatic cancer surgery-with arterial resection. First author DOI 10.21037/tgh.2019.01.07↗
  15. The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study. Co-author DOI 10.1016/j.hpb.2017.07.007↗

Closest collaborators

The 25 strongest of 61 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thilo Hackert · 11 shared papers, 2017–2023 · strength 1.37
  2. Markus Wolfgang Büchler · 9 shared papers, 2017–2023 · strength 1.09
  3. Ulla Klaiber · 7 shared papers, 2019–2023 · strength 0.96
  4. Oliver Strobel · 5 shared papers, 2017–2022 · strength 0.55
  5. Ulrike Heger · 4 shared papers, 2019–2023 · strength 0.52
  6. Christoph W. Michalski · 4 shared papers, 2017–2025 · strength 0.51
  7. Markus K. Diener · 4 shared papers, 2020–2022 · strength 0.48
  8. Masayuki Tanaka · 3 shared papers, 2019–2023 · strength 0.40
  9. Max Heckler · 3 shared papers, 2019–2023 · strength 0.40
  10. Martin A. Schneider · 3 shared papers, 2020–2022 · strength 0.36
  11. Can Yurttas · 1 shared paper, 2024 · strength 0.28
  12. Markus W. Loeffler · 1 shared paper, 2024 · strength 0.28
  13. Valerie Zimmermann · 1 shared paper, 2024 · strength 0.28
  14. Kuirong Jiang · 2 shared papers, 2021–2025 · strength 0.28
  15. Bo Kong · 2 shared papers, 2021–2025 · strength 0.27
  16. Hongzhen Li · 2 shared papers, 2021–2025 · strength 0.26
  17. Zhiheng Zhang · 2 shared papers, 2021–2025 · strength 0.26
  18. Helmut Friess · 2 shared papers, 2021–2025 · strength 0.26
  19. Jorg H. Kleeff · 2 shared papers, 2021–2025 · strength 0.26
  20. Xiaoping Zou · 2 shared papers, 2021–2025 · strength 0.26
  21. Martin Loos · 2 shared papers, 2021–2022 · strength 0.25
  22. John P. Neoptolemos · 2 shared papers, 2021 · strength 0.24
  23. Thomas Schmidt · 2 shared papers, 2020–2021 · strength 0.22
  24. Shigenori Ei · 1 shared paper, 2023 · strength 0.19
  25. Yazid J. Resheq · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.